The accompanying notes are an integral part of the financial statements.
The accompanying notes are an integral part of the financial statements.
The accompanying notes are an integral part of the financial statements.
The accompanying notes are an integral part of the financial statements.
NOTES TO FINANCIAL STATEMENTS
1. BUSINESS DESCRIPTION
Nature of Operations and Activities
Solitron Devices, Inc., a Delaware corporation (the “Company” or “Solitron”), designs, develops, manufactures, and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The Company was incorporated under the laws of the State of New York in 1959 and reincorporated under the laws of the State of Delaware in August 1987.
2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The financial statements have been prepared on the accrual basis of accounting in conformity with accounting principles generally accepted in the United States of America.
Use of estimates
The financial statements are prepared in accordance with U.S. GAAP. Preparation of these financial statements requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. The Company bases its estimates on historical experience and on various other assumptions that it believes to be reasonable. The Company could have reasonably used different accounting estimates. This applies in particular to inventory and valuation allowance for deferred tax assets. Actual results could differ significantly from our estimates. To the extent that there are material differences between these estimates and actual results, the Company’s future financial statement presentation, financial condition, results of operations and cash flows will be affected. The Company believes COVID-19 had a negative impact on the Company’s bookings in fiscal 2022, and bookings and net sales in fiscal 2023. The Company expects a negative impact to net sales in the first half of fiscal 2024 due to COVID-19 based on bookings being negatively affected in fiscal 2023.
Cash and Cash Equivalents
Cash and cash equivalents include demand deposits and money market accounts. The Company considers any short-term, highly liquid investments with maturities of three months or less as cash and cash equivalents.
Short-term Held-to-Maturity Investments
Short-term investments consist of certificates of deposit and U.S. Treasury securities. The U.S. Treasury securities are classified as held to maturity, mature in less than twelve months, and are reported at amortized cost which approximates fair value of $986,000 as of February 28, 2023.
Investment in Marketable Securities
Investment in Securities includes investments in equity securities. Investments in securities are reported at fair value with changes in unrecognized gains or losses included in other income on the statements of operations.
The following table summarizes the Company's marketable securities:
February 28, 2023 | | | | | Gross | | | Gross | | | | |
Marketable Securities: | | Cost | | | Unrealized Gains | | | Unrealized Losses | | | Fair Value | |
Common Stocks | | $ | 992,000 | | | $ | 930,000 | | | $ | (27,000 | ) | | $ | 1,895,000 | |
| | | | | | | | | | | | | | | | |
February 28, 2022 | | | | | | Gross | | | Gross | | | | | |
Marketable Securities: | | Cost | | | Unrealized Gains | | | Unrealized Losses | | | Fair Value | |
Common Stocks | | $ | 668,000 | | | $ | 42,000 | | | $ | (26,000 | ) | | $ | 684,000 | |
As of February 28, 2023, two securities accounted for $1,734,000 of the $1,895,000 balance in marketable securities, and $917,000 of the $930,000 in unrealized gains.
As of February 28, 2022 two securities were marked at the most recent trade in the security, versus the most recent statement value of zero. Both were expert market securities, these are over the counter securities where published bid and ask price is prohibited by the SEC under Rule 15c-211. One security was valued at $44,800, while the second was valued at $24,000. The Rule was not in effect as of February 28, 2021. These securities were sold in fiscal 2023.
At February 28, 2023 and February 28, 2022, the deferred tax liability related to unrecognized gains and losses on marketable securities was $229,000 and $0, respectively (see Note 7).
Fair Value of Financial Instruments
Accounting Standards Codification (“ASC”) Topic 820, “Fair Value Measurements and Disclosures” defines “fair value” as the price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also sets forth a valuation hierarchy of the inputs (assumptions that market participants would use in pricing an asset or liability) used to measure fair value. This hierarchy prioritizes the inputs into the following three levels:
Level 1. Observable inputs that reflect unadjusted quoted prices for identical assets or liabilities traded in active markets.
Level 2: Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly.
Level 3: Inputs that are generally unobservable. These inputs may be used with internally developed methodologies that results in management’s best estimate of fair value.
The table below shows the company’s marketable securities as of February 28, 2023 and February 28, 2022.
February 28, 2023 | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Common Stocks | | $ | 1,895,000 | | | $ | - | | | $ | - | | | $ | 1,895,000 | |
Limited Partnerships | | $ | - | | | $ | - | | | $ | - | | | $ | - | |
Total | | $ | 1,895,000 | | | $ | - | | | $ | - | | | $ | 1,895,000 | |
| | | | | | | | | | | | | | | | |
February 28, 2022 | | Level 1 | | | Level 2 | | | Level 3 | | | Total | |
Common Stocks | | $ | 603,000 | | | $ | 69,000 | | | $ | - | | | $ | 672,000 | |
Limited Partnerships | | $ | 12,000 | | | $ | - | | | $ | - | | | $ | 12,000 | |
Total | | $ | 615,000 | | | $ | 69,000 | | | $ | - | | | $ | 684,000 | |
The carrying amounts of the Company’s short-term financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, accrued expenses and other liabilities approximate their fair value due to the relatively short period to maturity for these instruments. The carrying value of long-term debt approximates fair value since the related rates of interest approximate current market rates.
Accounts Receivable
Accounts receivable consists of unsecured credit extended to the Company’s customers in the ordinary course of business. The Company reserves for any amounts deemed to be uncollectible based on past collection experiences and an analysis of outstanding balances using an allowance amount. The allowance amount was $0 as of February 28, 2023 and February 28, 2022.
Shipping and Handling
Shipping and handling costs billed to customers are recorded in net sales. Shipping costs incurred by the Company are recorded in cost of sales.
Inventories
Inventories are stated at the lower of cost and net realizable value. Cost is determined using the “first-in, first-out” (FIFO) method. The Company buys raw material only to fill customer orders. Excess raw material is created only when a vendor imposes a minimum quantity buy in excess of actual requirements. Such excess material will usually be utilized to meet the requirements of the customer’s subsequent orders. If excess material is not utilized after two fiscal years, it is fully reserved. Any inventory item once designated as reserved is carried at zero value in all subsequent valuation activities. Through February 28, 2022, the Company maintained a three inch wafer fab which procured raw wafers and produced finished wafers based on management’s estimates of projected future demand. Finished wafers are considered work-in-process since they are usable for many years, and in some circumstances can be used on more than one finished product depending on customer parameters.
The Company does not classify a portion of inventories as non-current since we cannot reasonably estimate based on the length of our operating cycle which items will or will not be used within twelve months.
The Company’s inventory valuation policy is as follows:
Raw material /Work in process: | | All material acquired or processed in the last two fiscal years is valued at the lower of its acquisition cost or net realizable value, except for wafers which functioned under a three-year policy. All material not used after two fiscal years is fully reserved for except wafers which were reserved for after three years. All raw wafers were fully reserved for when the wafer fab was decommissioned. Finished wafers produced in our former wafer fab are stored in the wafer bank and are considered work-in-process. Raw material in excess of five years’ usage that cannot be restocked, and slow-moving work in process are reserved for. |
| | |
Finished goods: | | All finished goods with firm orders for later delivery are valued (material and overhead) at the lower of cost or net realizable value. All finished goods with no orders are fully reserved. |
| | |
Direct labor costs: | | Direct labor costs are allocated to finished goods and work in process inventory based on engineering estimates of the amount of man-hours required from the different direct labor departments to bring each device to its particular level of completion. Manufacturing overhead costs are allocated to finished goods and work in process inventory as a ratio to direct labor costs. |
Property, Plant, Equipment, and Leasehold Improvements
Property, plant, and equipment is recorded at cost. Major renewals and improvements are capitalized, while maintenance and repairs that do not extend their expected life are expensed as incurred. Depreciation is provided on a straight-line basis over the estimated useful lives of the related assets. Leasehold improvements are amortized over the shorter of the lease term or the lives of the related assets:
Building | | 39 years | |
Building Improvements | | 15 years | |
Leasehold Improvements | | 10 years | |
Machinery and Equipment | | 5 years | |
Concentrations of Credit Risk
Financial instruments, which potentially subject the Company to concentration of credit risk, consist principally of cash and account receivables. The Company places its cash with high credit quality institutions. At times, such amounts may be in excess of the Federal Deposit Insurance Corporation (“FDIC”) insurance limits. The Company has not experienced any losses in such accounts and believes that it is not exposed to any significant credit risk on the accounts. As of February 28, 2023, and February 28, 2022, all non-interest bearing checking accounts were FDIC insured to a limit of $250,000. Deposits in excess of FDIC insured limits were approximately $129,000 at February 28, 2023 and $3,448,000 at February 28, 2022. With respect to the account receivables, most of the Company’s products are custom made pursuant to contracts with customers whose end-products are sold to the United States Government. The Company performs ongoing credit evaluations of its customers’ financial condition and maintains allowances for potential credit losses. Actual losses and allowances have historically been within management’s expectations.
Revenue Recognition
The Company records revenue in accordance with ASC 606, Revenues from Contracts with Customers (Topic 606) which requires an entity to recognize the amount of revenue to which it expects to be entitled for the transfer of promised goods and services to customers. Revenue is recognized at a point in time, generally upon shipment of products to customers.
The core principle of the guidance in Topic 606 is that an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services.
To achieve that core principle, the Company applied the following steps:
1. Identify the contract(s) with a customer.
The Company designs, develops, manufactures and markets solid-state semiconductor components and related devices. The Company’s products are used as components primarily in the military and aerospace markets.
The Company’s revenues are from purchase orders and/or contracts with customers associated with manufacture of products. We account for a contract when it has approval and commitment from both parties, the rights of the parties are identified, payment terms are identified, the contract has commercial substance and collectability of consideration is probable.
2. Identify the performance obligations in the contract.
The majority of the Company’s purchase orders or contracts with customers contain a single performance obligation, the shipment of products.
3. Determine the transaction price.
The transaction price reflects the Company’s expectations about the consideration it will be entitled to receive from the customer at a fixed price per unit shipped based on the terms of the contract or purchase order with the customer. To the extent our actual costs vary from the fixed price that was negotiated, we will generate more or less profit or could incur a loss.
4. Allocate the transaction price to the performance obligations in the contract.
5. Recognize revenue when (or as) the Company satisfies a performance obligation.
This performance obligation is satisfied when control of the product is transferred to the customer, which generally occurs upon shipment. The Company receives purchase orders for products to be delivered over multiple dates that may extend across reporting periods. The Company accounting policy treats shipping and handling activities as a fulfillment cost. The Company invoices for each order upon shipment and recognizes revenues at the fixed price for each distinct product sold when transfer of control has occurred, which is generally upon shipment.
In addition, the Company may have a contract or purchase order to provide a non-recurring engineering service to a customer. These contracts are reviewed and performance obligations are determined and we recognize revenue at the point in time in which each performance obligation is fully satisfied.
We recognize revenue on sales to distributors when the distributor takes control of the products ("sold-to" model). We have agreements with distributors that allow distributors a limited credit for unsaleable products, which we refer to as a "scrap allowance." Consistent with industry practice, we also have a "stock, ship and debit" program whereby we consider requests by distributors for credits on previously purchased products that remain in distributors' inventory, to enable the distributors to offer more competitive pricing. We have contractual arrangements whereby we provide distributors with protection against price reductions initiated by us after product is sold by us to the distributor and prior to resale by the distributor. In addition, we have a termination clause in one of our distributor agreements that would allow for a full credit for all inventory upon 60 days notice of terminating the agreement.
We recognize the estimated variable consideration to be received as revenue and record a related accrued expense for the consideration not expected to be received, based upon an estimate of product returns, scrap allowances, "stock, ship and debit" credits, and price protection credits that will be attributable to sales recorded through the end of the period. We make these estimates based upon sales levels to our customers during the period, inventory levels at the distributors, current and projected market conditions, and historical experience under the programs. Our estimates require the exercise of significant judgments. We believe that we have a reasonable basis to estimate future credits under the programs.
Related Party Transactions
The Company currently purchases and has purchased in the past die and wafers, as specified by the Company's customers, from ES Components. Mr. Aubrey, a director of the Company, is a minority owner, and an immediate family member of Mr. Aubrey is the majority owner of ES Components. For the fiscal year ended February 28, 2023, the Company purchased $116,000 of die and $0 of used equipment from ES Components. For the fiscal year ended February 28, 2022, the Company purchased $112,000 of die and $0 of used equipment from ES Components. The Company has included these expenses in cost of goods sold in the accompanying statement of operations. The Company occasionally makes sales to ES Components. For the fiscal years ended February 28, 2023 and February 28, 2022 sales were $0.
Income Taxes
Income taxes are accounted for under the asset and liability method of ASC 740-10, “Income Taxes”. Deferred tax assets and liabilities are recognized for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. Under ASC 740-10, the effect on deferred tax assets and liabilities or a change in tax rate is recognized in income in the period that includes the enactment date. Deferred tax assets are reduced to estimated amounts to be realized by the use of a valuation allowance.
The Company accounts for the uncertainty in income taxes in accordance with ASC 740-10 and evaluates its tax positions utilizing a two-step process. The first step is to determine whether it is more-likely-than-not that a tax position will be sustained upon examination based on the technical merits of the position. The second step is to measure the benefit to be recorded from tax positions that meet the more-likely-than-not recognition threshold by determining the largest amount of tax benefit that is greater than 50 percent likely of being realized upon ultimate settlement and recognizing that amount in the financial statements.
Refer to Note 7 for additional information on income taxes.
Net Income (Loss) Per Common Share
Net income/loss per common share is presented in accordance with ASC 260-10 “Earnings per Share.” Basic earnings per common share are computed using the weighted average number of common shares outstanding during the period. Diluted earnings per common share incorporate the incremental shares issuable upon the assumed exercise of stock options to the extent they are not anti-dilutive using the treasury stock method. The Company had no potentially dilutive securities outstanding during the fiscal years ended February 28, 2023 and February 28, 2022, therefore there is no effect from dilution on earnings per share.
Impairment of long-lived assets
Potential impairments of long-lived assets are reviewed annually or when events and circumstances warrant an earlier review. In accordance with ASC Subtopic 360-10, “Property, Plant and Equipment – Overall,” impairment is determined when estimated future undiscounted cash flows associated with an asset are less than the asset’s carrying value. No impairment losses were incurred during the fiscal years ended February 28, 2023 and 2022.
Financial Statement Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates and the differences could be material. Such estimates include variable consideration related to revenue recognition, stock-based compensation, depreciable life of property and equipment, accounts receivable allowance, deferred tax valuation allowance, and allowance for inventory obsolescence.
Stock based compensation
The Company records stock-based compensation in accordance with the provisions of ASC Topic 718, “Compensation-Stock Compensation,” which establishes accounting standards for transactions in which an entity exchanges its equity instruments for goods or services. Under ASC Topic 718, the Company recognizes an expense for the fair value of outstanding stock options and grants as they vest, whether held by employees or others. There are no stock options outstanding, and no options were granted or vested during the fiscal years ended February 28, 2023 and February 28, 2022 under the Company’s 2019 Stock Incentive Plan.
Leases
The Company capitalizes all leased assets pursuant to ASU 2016-02, “Leases (Topic 842),” which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases. The Company excludes short-term leases having initial terms of 12 months or less from Topic 842 as an accounting policy election and recognizes rent expense on a straight-line basis over the lease term.
Recent Accounting Pronouncements
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,” which significantly changes the impairment model for most financial instruments. Current guidance requires the recognition of credit losses based on an incurred loss impairment methodology that reflects losses once the losses are probable. Under the new standard, the Company will be required to use a current expected credit loss model (“CECL”) that will immediately recognize an estimate of credit losses that are expected to occur over the life of the consolidated financial instruments that are in the scope of this update, including trade receivables. The CECL model uses a broader range of reasonable and supportable information in the development of credit loss estimates. The Company will adopt the new guidance on a modified retrospective basis beginning with its first fiscal quarter of 2024. The adoption of this guidance is not expected to have a material impact on our financial statements.
The Company does not believe that any recently issued effective pronouncements, or pronouncements issued but not yet effective, if adopted, would have a material effect on the accompanying financial statements.
3. REVENUE RECOGNITION
As of February 28, 2023, and February 28, 2022, sales returns and allowances accrual activity is shown below:
| | February 28, 2023 | | | February 28, 2022 | |
Beginning Balance | | $ | 471,000 | | | $ | 354,000 | |
Accrued Allowances | | | - | | | | 117,000 | |
Credits Issued | | | - | | | | - | |
Ending Balance | | $ | 471,000 | | | $ | 471,000 | |
As noted in Note 2 above, one of our distributor agreements has a termination clause that would allow for a full credit for all inventory upon 60 days notice of terminating the agreement. As of February 28, 2023 and February 28, 2022, the inventory balance at that distributor was $1,784,000 and $2,178,000, respectively. Based upon sales levels to and by the distributor during the period, inventory levels at the distributor, current and projected market conditions, and historical experience under the program, we believe it is highly unlikely that the distributor would exercise termination. Should it occur, we believe the products could be sold to other distributors or held in inventory for future sale.
The Company warrants that its products, when delivered, will be free from defects in material workmanship under normal use and service. The obligations are limited to replacing, repairing, or reimbursing for, at the option of the Company, any products that are returned within one year after the date of shipment. The Company does not reserve for potential warranty costs based on historical experience and the nature of its cost tracking system.
4. INVENTORIES
As of February 28, 2023, inventories consist of the following:
| | Gross | | | Reserve | | | Net | |
Raw Materials | | $ | 1,329,000 | | | $ | (460,000 | ) | | $ | 869,000 | |
Work-In-Process | | | 5,215,000 | | | | (3,800,000 | ) | | | 1,415,000 | |
Finished Goods | | | 597,000 | | | | (466,000 | ) | | | 131,000 | |
Totals | | $ | 7,141,000 | | | $ | (4,726,000 | ) | | $ | 2,415,000 | |
As of February 28, 2022, inventories consist of the following:
| | Gross | | | Reserve | | | Net | |
Raw Materials | | $ | 1,504,000 | | | $ | (813,000 | ) | | $ | 691,000 | |
Work-In-Process | | | 5,410,000 | | | | (3,906,000 | ) | | | 1,504,000 | |
Finished Goods | | | 723,000 | | | | (658,000 | ) | | | 65,000 | |
Totals | | $ | 7,637,000 | | | $ | (5,377,000 | ) | | $ | 2,260,000 | |
Wafer related inventory, which included raw wafers and work-in-process wafers through February 28, 2022, and wafer bank (completed wafers that are available to be consumed in the Company’s products) during both fiscal years, net of reserves, totaled $589,000 as of February 28, 2023 and $965,000 as of February 28, 2022. As of February 28, 2023, 100% of the wafer bank inventory consisted of wafers manufactured between calendar year 2018 and 2022. We do not expect all of our wafer inventory to be consumed within twelve months; however, since it is not possible to know which wafers will or will not be used, we classify all our inventory as current.
5. PROPERTY, PLANT AND EQUIPMENT
As of February 28, 2023, and February 28, 2022, property, plant, and equipment consist of the following:
| | February 28, 2023 | | | February 28, 2022 | |
Land | | $ | 1,550,000 | | | $ | 1,550,000 | |
Building | | | 5,111,000 | | | | 2,650,000 | |
Construction in Progress | | | - | | | | 609,000 | |
Leasehold Improvements | | | 287,000 | | | | 287,000 | |
Motor Vehicles | | | 88,000 | | | | 88,000 | |
Computer Equipment | | | 27,000 | | | | 27,000 | |
Machinery and Equipment | | | 4,986,000 | | | | 4,649,000 | |
Subtotal | | | 12,049,000 | | | | 9,860,000 | |
Less: Accumulated Depreciation and Amortization | | | (4,689,000 | ) | | | (4,325,000 | ) |
Net Property, Plant and Equipment | | $ | 7,360,000 | | | $ | 5,535,000 | |
Depreciation and amortization expense was $363,000 and $264,000 for the fiscal years ended February 28, 2023 and February 28, 2022, respectively, and is included in cost of sales in the accompanying statements of operations.
We did not relocate our wafer fab to our new facility. Certain wafer fab equipment with a net book value as of February 28, 2022 of $0 was not transferred to our new facility and was sold as scrap.
6. ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES
As of February 28, 2023, and February 28, 2022, accrued expenses and other current liabilities consist of the following:
| | February 28, 2023 | | | February 28, 2022 | |
Payroll and related employee benefits | | $ | 363,000 | | | $ | 375,000 | |
Legal fees | | | 3,000 | | | | 8,000 | |
Property, sales, and franchise taxes | | | 20,000 | | | | 18,000 | |
Return allowance | | | 471,000 | | | | 471,000 | |
Other liabilities | | | 50,000 | | | | 16,000 | |
Totals | | $ | 907,000 | | | $ | 888,000 | |
7. INCOME TAXES
The Company did not have a provision for income taxes (current or deferred tax expense) for tax years ended February 28, 2023, and February 28, 2022.
A reconciliation of the U.S. federal statutory tax rate to the Company’s effective tax rate for fiscal year ended February 28, 2023, and February 28, 2022, is as follows:
| | 2023 | | | | | | 2022 | | | | |
Net Income/(Loss) Before Taxes | | | 826,000 | | | | | | | 3,508,000 | | | | |
| | | | | | | | | | | | | | |
Provision/(Benefit) at statutory rate | | | 173,000 | | | | 21.0 | % | | | 737,000 | | | | 21.0 | % |
State Tax Provision/(Benefit) net of federal benefit | | | 55,000 | | | | 6.7 | % | | | 56,000 | | | | 1.6 | % |
Permanent Book/Tax Differences | | | - | | | | 0.0 | % | | | (170,000 | ) | | | -4.8 | % |
Change in Valuation Allowance | | | (166,000 | ) | | | -20.1 | % | | | (623,000 | ) | | | -17.8 | % |
R&D Credit | | | (50,000 | ) | | | -6.1 | % | | | | | | | | |
True-Up & Adjustments | | | (12,000 | ) | | | -1.5 | % | | | - | | | | 0.0 | % |
Other | | | - | | | | 0.0 | % | | | - | | | | 0.0 | % |
Income Tax Provision / (Benefit) | | | - | | | | | | | | - | | | | | |
Effective income tax rate | | | 0.00 | % | | | | | | | 0.00 | % | | | | |
Total net deferred taxes are comprised of the following at February 28, 2023 and February 28, 2022:
Deferred Tax Asset (Liability): | | 2023 | | | 2022 | |
Accrued Liabilities | | $ | 59,000 | | | $ | 49,000 | |
Inventory Allowance | | | 1,198,000 | | | | 1,363,000 | |
Allowance for Sales Reserve | | | 119,000 | | | | - | |
Net Operating Loss Carryforwards | | | 2,577,000 | | | | 2,065,000 | |
Other | | | 8,000 | | | | 14,000 | |
Capitalized R&D | | | 119,000 | | | | - | |
Unrealized Gains | | | (229,000 | ) | | | - | |
Depreciation | | | (658,000 | ) | | | (132,000 | ) |
Total Deferred Tax Assets (Liabilities) | | | 3,193,000 | | | | 3,359,000 | |
Valuation allowance | | | (3,193,000 | ) | | | (3,359,000 | ) |
| | $ | - | | | $ | - | |
A valuation allowance is recorded to reduce the deferred tax asset if, based on the weight of the evidence, it is more likely than not that some portion or all of the deferred tax asset will not be realized. After consideration of all the evidence, both positive and negative, management has determined that a valuation allowance of $3,193,000 and $3,359,000 for the years ended on February 28, 2023 and February 28, 2022 respectively, is necessary to reduce the deferred tax asset to the amount that will more likely than not be realized.
On March 27, 2020, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act was enacted and signed into law. Certain provisions of the CARES Act could impact the 2019 income tax provision computations of the Company and will be reflected in the period of enactment (tax year 2020). The CARES Act, among other things, contains modifications on the limitation of business interest expense under Section 163(j), allow for NOL carryovers and carrybacks to offset 100% of taxable income for taxable years before 2021, and includes a technical correction to the TCJA with respect to Qualified Improvement Property ("QIP") where such property has a 15-year recovery period for purposes of the general depreciation system of Section 168(a). The Company has evaluated the impact of the CARES Act, and it believes that none of the modifications or tax law changes will result in any material benefit.
As of February 28, 2023, the Company estimates it has approximately $10.7 million of Federal and $7.8 million of state net operating loss (“NOL”) carryforwards as compared to $9.1 million of Federal and $6.2 million of state net operating loss carryforwards as of February 28, 2022. The remaining balance of federal NOL carryforwards will begin to expire in 2029. Such net operating losses are available to offset future taxable income, if any. As the utilization of such net operating losses for tax purposes is not assured, the deferred tax asset has been fully reserved through the recording of a 100% valuation allowance.
Under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, (the Code), substantial changes in the Company’s ownership may limit the amount of net operating loss and research and development credit carryforwards that could be used annually in the future to offset taxable income. A formal Section 382 study has not been completed to determine if an ownership change has occurred and if its net operating losses are subject to an annual limitation. Such annual limitations could affect the utilization of NOL and tax credit carryforwards in the future.
The Federal net operating loss carryforwards will expire as follows:
Fiscal Year Ending February 28/29 | | Amount | |
2029 | | | 7,107,000 | |
2037 | | | 322,000 | |
indefinite | | | 3,226,000 | |
Total | | $ | 10,655,000 | |
8. STOCK OPTIONS
There are no stock options outstanding and no options have been granted during the fiscal years ended February 28, 2023 and February 28, 2022 under the Company’s 2019 Stock Incentive Plan.
9. EMPLOYEE BENEFIT PLANS
The Company has a 401k and Profit Sharing Plan (the “Profit Sharing Plan”) in which substantially all employees may participate after three months of service. Contributions to the Profit Sharing Plan by participants are voluntary. The Profit Sharing Plan allows for matching and discretionary employer contributions. In addition, the Company may make additional contributions at its discretion. The Company did not contribute to the Profit Sharing Plan during the fiscal years ended February 28, 2023 and February 28, 2022.
10. DISAGGREGATION OF REVENUES AND MAJOR CUSTOMERS
Revenues from domestic and export sales to unaffiliated customers for the fiscal years ended February 28, 2023, and February 28, 2022, are as follows:
Geographic Region | | February 28, 2023 | | | February 28, 2022 | |
Europe and Australia | | $ | 459,000 | | | $ | - | |
Canada and Latin America | | | 20,000 | | | | 27,000 | |
Far East and Middle East | | | - | | | | 9,000 | |
United States | | | 5,927,000 | | | | 12,248,000 | |
Totals | | $ | 6,406,000 | | | $ | 12,284,000 | |
Revenues from domestic and export sales are attributed to global geographic regions according to the location of the customer’s primary manufacturing or operating facilities.
For the fiscal years ended February 28, 2023, and February 28, 2022, approximately 81% and 85%, respectively, of the Company’s sales have been attributable to contracts with customers whose products are sold to the United States government. The remaining 19% and 15%, respectively of sales are for non-military, scientific and industrial applications, or to distributors where we do not have end user information.
For the year ended February 28, 2023, sales to Raytheon Technologies Corporation accounted for approximately 46% of net sales. No other customer accounted for more than 10% of net sales.
For the year ended February 28, 2022, sales to Raytheon Technologies Corporation accounted for approximately 47% of net sales, sales to L3Harris Technologies accounted for 15% of net sales, sales to USI Electronics accounted for 13% of net sales, and sales to Honeywell accounted for 11% of net sales.
11. MAJOR SUPPLIERS
For the year ended February 28, 2023, purchases from the Company’s top supplier, Platronics Seals accounted for 21% of the Company's total purchases of production materials. Other suppliers that represented more than 10% of total purchases were Wuxi Streamtek, which accounted for 16% of total purchases, and Stellar Industries, which accounted for 15% of total purchases.
For the year ended February 28, 2022, purchases from the Company’s top supplier, Platronics Seals accounted for 25% of the Company's total purchases of production materials. Other suppliers that represented more than 10% of total purchases were Wuxi Streamtek, which accounted for 22% of total purchases, and Stellar Industries, which accounted for 12% of total purchases.
12. COMMITMENTS AND CONTINGENCIES
Finance lease:
During fiscal 2021 the Company entered into a 36-month finance lease for $27,000 of computer equipment. The Company does not consider the lease to be material to the Company’s financial statements. As of February 28, 2023 and February 28, 2022 fiscal year end, the carrying value of the asset was $3,000 and $12,000, respectively, and was included in Property, plant and equipment on the balance sheets.
Operating lease:
On October 1, 2014, the Company extended its lease with its then landlord, CF EB REO II LLC, for the occupancy and use of a 47,000 square foot facility located at 3301 Electronics Way, West Palm Beach, Florida 33407 (the “Lease”). The property subsequently was sold to La Boheme Properties, Inc., a Florida corporation, and the Lease was assigned to them. The term of the Lease ended on December 31, 2021. The base rent provided in the Lease is $31,555 per month, excluding sales tax. The company continued to rent a portion of the facility on a month-to-month basis until completion of the relocation to its new facility in fiscal 2023.
Due to the lease expiration there was no balance sheet classification of operating lease assets and liabilities as of February 28, 2023. The balance sheet classification of operating lease assets and liabilities as of February 28, 2022, were as follows:
Balance Sheet Classification | | February 28, 2022 | |
Assets | | | |
Operating lease right-of-use assets, March 1, 2021 | | $ | 340,000 | |
Amortization for fiscal year ended February 28, 2022 | | | (340,000 | ) |
Total operating lease right-of-use asset, February 28, 2022 | | $ | - | |
Liabilities | | | | |
Current | | | | |
Operating lease liability, short-term | | $ | - | |
Non-current | | | | |
Operating lease liability, long-term | | | - | |
Total lease liabilities | | $ | - | |
Actual rent expense paid for the fiscal years ended February 28, 2023 and February 28, 2022 including Florida sales tax was approximately $75,000 and $457,000, respectively.
Contingencies:
We may from time to time become a party to various legal proceedings arising in the ordinary course of business. As of February 28, 2023, we had no known material current, pending, or threatened litigation.
13. NOTES PAYABLE
On July 21, 2020, the Company received loan proceeds of $807,415 under the Paycheck Protection Program (the “PPP Loan”). The Paycheck Protection Program (“PPP”) was established under the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) and is administered by the U.S. Small Business Administration (“SBA”). The PPP Loan to the Company was made through Bank of America, N.A., a national banking association. The PPP Loan was scheduled to mature on July 21, 2025 and bore interest at a rate of 1% per annum. Payments of principal and interest on the loan were initially deferred until January 1, 2021 and based on applying for forgiveness the deferral was extended through October 31, 2021. The Note could have been prepaid by the Company at any time prior to maturity with no prepayment penalties. Funds from the PPP Loan may only be used for payroll costs, costs used to continue group health care benefits, mortgage payments, rent, utilities, and interest on certain other debt obligations. The Company used the entire PPP Loan amount for qualifying expenses. Under the terms of the PPP, certain amounts of the PPP Loan may be forgiven if they are used for qualifying expenses as described in the CARES Act.
On June 12, 2021 the SBA notified Bank of America that the Company’s application for complete forgiveness of its PPP loan was approved.
On April 16, 2021, the Company closed on the acquisition of a facility and real estate located in West Palm Beach, Florida for a purchase price of $4,200,000 pursuant to the Commercial Contract entered into on March 1, 2021. In connection with the acquisition, the Company obtained mortgage financing from Bank of America, N.A. (the “Bank”) in the amount of $2,940,000 to fund that portion of the total purchase price, and entered into the Master Credit Agreement, a Note, a Mortgage, Assignment of Rents, Security Agreement and Fixture Filing and Financial Covenant Agreement (the “FCA”). The loan accrues interest at a fixed rate of 3.8% per year and matures on April 15, 2031. Beginning on May 15, 2021 the Company began making monthly installments of $17,593 consisting of principal and interest. The payment and performance of the loan is secured by a security interest in the property acquired. The Master Credit Agreement contains certain representations and warranties, undertakings and events of default customary for these types of agreements. Additionally, under the terms of the FCA, the Company has agreed to maintain a fixed charge coverage ratio of at least 1.15:1.0, calculated at the end of each fiscal year, using the results of the twelve-month period ending with that reporting period, and has agreed to maintain on a consolidated basis a minimum of no less than $1,000,000 of unrestricted, unencumbered liquid assets.
On June 29, 2022, the Company received notification from the Bank that it had elected to suspend certain financial and reporting requirements set forth in the FCA. Specifically, the Bank elected on a going forward basis to suspend measurement of any of the following financial covenants to the extent they are included in Section 2.1, ‘Financial Covenants’ of the FCA: Tangible Net Worth; Debt Service Coverage Ratio; Fixed Charge Coverage Ratio; Asset Coverage Ratio; Funded Debt to EBITDA; and/or Liquidity. In addition, the Bank elected to suspend the requirements in the FCA, if any, for the submission of financial statements and information by the Borrower on a periodic basis as specified in Section 2.4, ‘Financial Information’ of the FCA. The Bank reserves the right in its sole discretion to require the Company to resume delivery of financial statements and other information and to evidence compliance with the financial covenant requirements as currently provided in the FCA.
14. STOCKHOLDERS’ EQUITY
Repurchase Program
The Board of Directors has authorized a stock repurchase program of up to $1.0 million of its outstanding common stock Purchases under the program may be made through the open market or privately negotiated transactions as determined by the Company’s management, and in accordance with the requirements of the Securities and Exchange Commission. The timing and actual number of shares repurchased will depend on variety of factors including price, corporate and regulatory requirements and other conditions.
During the fiscal year ended February 28, 2023, the Company did not repurchase shares of common stock. During the fiscal year ended February 28, 2022, the Company repurchased 16 shares of common stock.